PVNNF

 
Ordinary Shares SEC Reporting - Current
Pink Current Information
Verified Company Profile 8/29/2017
Contact Info
  • 8 Hamasger Street
  • Migdal HaEmek 2310102
  • Israel

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 20-F
CIK 0001627480
Fiscal Year End 12/31
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2890 - Miscellaneous Chemical Products
Incorporated In: Israel
Year of Inc. 2009
Employees 10 a/o Aug 28, 2017
Company Officers/Contacts
Dr. Fernando De La Vega CEO
Company Directors
Dr. Astorre Modena Chairman
Steven Hsieh
Dr. Harold Wiener
Service Providers
Investment Bank
Sunrise Securities Corp.
1330 Avenue of the Americas
36th Floor
New York, NY, 10019
United States
 
Accounting/Auditing Firm
Kost Forer Gabbay & Kasierer
3 Aminadav St.
Tel-Aviv, 67067
Israel
 
Securities Counsel
Greenberg Traurig LLP OTCQX Sponsor
1201 K Street
Suite 1100
Sacramento, CA, 95814
United States
 
Investor Relations Firm

Not Available
PVNNF Security Details
Share Structure
Market Value1 $22,002,688 a/o Oct 18, 2017
Authorized Shares Unlimited a/o Oct 10, 2017
Outstanding Shares 14,668,459 a/o Oct 10, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 2,021,871 a/o Mar 28, 2017
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 45 a/o Aug 28, 2017
Short Selling Data
Short Interest 20 (100%)
Aug 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security